Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease
- 1 January 1973
- journal article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 280 (4) , 429-439
- https://doi.org/10.1007/bf00506633
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- CLINICAL ANALYSES OF FACTORS INFLUENCING L‐DOPA TREATMENT OF PARKINSON'S SYNDROMEActa Medica Scandinavica, 1972
- Decarboxylation of orally administered l-dopa in the human digestive tractNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- l-3,4-dihydroxyphenylalanine metabolism by the GUT IN VITROBiochemical Pharmacology, 1971
- Phenylalanine Absorption and Metabolism in Parkinsonian PatientsBMJ, 1971
- Absorption and Metabolism of L‐Dopa by the Human StomachEuropean Journal of Clinical Investigation, 1971
- Decrease in Liver Aromatic L-Amino-Acid Decarboxylase Produced by Chronic Administration of L-DopaProceedings of the National Academy of Sciences, 1971
- METABOLISM AND ABSORPTION OF l‐3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSON'S DISEASEAnnals of the New York Academy of Sciences, 1971
- Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral l-dopaClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].1970
- Drug-Induced Changes of Extracerebral Dopa Metabolism in ManArchives of Neurology, 1969